SCHEMBL207130

SCHEMBL207130

CN(CCCNC(=O)CCC(=O)NC1CCC(Cc2cccc(Cl)c2)(N(C)C)CC1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.42
SIGMAR1 Q99720 2/20 0.41
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 3/20 0.41
EPHX2 P34913 2/20 0.41
HPGD P15428 3/20 0.41
THRB P10828 1/20 0.41
TMEM97 Q5BJF2 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
GFER P55789 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
OPRM1 P35372 3/20 0.39
OPRL1 P41146 3/20 0.39
MEN1 O00255 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
USP2 O75604 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207910 0.90 OPRM1 (0.50) SMN1; SMN2SIGMAR1ALDH1A1KMT2AEPHX2
SCHEMBL208454 0.88 ALDH1A1 (0.53) SMN1; SMN2SIGMAR1ALDH1A1KMT2AEPHX2
SCHEMBL205735 0.86 ALDH1A1 (0.55) SMN1; SMN2SIGMAR1ALDH1A1KMT2AEPHX2
SCHEMBL207808 0.84 HPGD (0.55) SMN1; SMN2SIGMAR1ALDH1A1KMT2AHPGD
SCHEMBL206988 0.83 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1KMT2AEPHX2HPGD
SCHEMBL5470487 0.83 SIGMAR1 (0.41) SMN1; SMN2SIGMAR1ALDH1A1KMT2AEPHX2
SCHEMBL208794 0.83 ALDH1A1 (0.44) SMN1; SMN2SIGMAR1ALDH1A1KMT2AEPHX2
Hydrochloric Acid SCHEMBL206061 0.82 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1KMT2AEPHX2HPGD
SCHEMBL206772 0.82 EPHX2 (0.47) SIGMAR1ALDH1A1KMT2AEPHX2HPGD
SCHEMBL206288 0.82 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1KMT2AEPHX2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD SMN1; SMN2 1061/4885SIGMAR1 3262/4885ALDH1A1 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.